Mozobil™ Increases Autologous Peripheral Blood Stem Cell Harvests … – Cancer Consultants
May 7, 2009
|
Mozobil™ Increases Autologous Peripheral Blood Stem Cell Harvests …
Cancer Consultants, ID Mozobil was approved by the US Food and Drug Administration in December of 2008 for use with Neupogen for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma. A Phase II study suggested that … |